phenomenon · claim-type · cross-domain-transfer · mechanism · claim-relation · replication-status · limitation — grounded in the full text| phenomenon | a controlled vocabulary whose own authors apply it non-uniformly, revised by consensus every two years against evidence that arrives between meetings— “Survey among renal pathologists (including very experienced) revealed nonuniform application of current Banff TCMR cutoffs, consideration of non‐Banff lesions in TCMR diagnosis, grading or nongrading of i‐IFTA.” | |
| claim-type | method— “Thus, at present and to minimize overdiagnosis, tubulointerstitial lesions of chronic active TCMR have been added to the working classification (Table 5 ) as a combination of i‐IFTA and tubulitis involving all but severely atrophic tubules, with moderately high thresholds for both (i‐IFTA2‐3; t2‐3), a requirement for inflammation involving… | |
| method — evidence | — “Possible incorporation of i‐IFTA into classification; possible elimination of borderline category; reevaluate thresholds for i and t and possible addition of other findings (eg, edema) to TCMR diagnostic criteria.” | |
| object of study — evidence | — “In confirmation of previous studies, it was independently demonstrated by 2 groups that i‐ IFTA is associated with reduced graft survival. Furthermore, these groups presented that i‐ IFTA , particularly when involving >25% of sclerotic cortex in association with tubulitis, is often a sequela of acute TCMR in association with… | |
| research question — evidence | — “Thus, at present and to minimize overdiagnosis, tubulointerstitial lesions of chronic active TCMR have been added to the working classification (Table 5 ) as a combination of i‐IFTA and tubulitis involving all but severely atrophic tubules, with moderately high thresholds for both (i‐IFTA2‐3; t2‐3), a requirement for inflammation involving… | |
| contribution — evidence | — “In confirmation of previous studies, it was independently demonstrated by 2 groups that i‐ IFTA is associated with reduced graft survival. Furthermore, these groups presented that i‐ IFTA , particularly when involving >25% of sclerotic cortex in association with tubulitis, is often a sequela of acute TCMR in association with… | |
| mechanism | THE VOCABULARY'S OWN AUTHORS DO NOT APPLY IT UNIFORMLY, AND THE PAPER SAYS SO IN ITS OWN WORKING-GROUP REPORT: `Survey among renal pathologists (including very experienced) revealed nonuniform application of current Banff TCMR cutoffs, consideration of non-Banff lesions in TCMR diagnosis, grading or nongrading of i-IFTA.` This corpus has records of vocabularies that failed on measurement (laubach2018) and of definitions that disagreed across papers; this is a body measuring the DISPERSION OF ITS OWN USERS and printing the result— “Survey among renal pathologists (including very experienced) revealed nonuniform application of current Banff TCMR cutoffs, consideration of non‐Banff lesions in TCMR diagnosis, grading or nongrading of i‐IFTA.” | mechanisms[0] |
| mechanism | AND A WORD WAS REMOVED FROM THE CLASSIFICATION FOR A COMMUNICATIVE REASON, NOT A SCIENTIFIC ONE: `The term `ACUTE` (in acute/active ABMR) is confusing to clinicians, and consequently it has been removed from the Banff classification`. Nothing about the disease changed. The term was deleted because readers misread it - the same shape as macdonald2015 (WHO SAGE taking the narrower name for the broader concept for institutional reasons) and the ICTV's published change types, and the plainest case in the corpus of a definition edited for its AUDIENCE— “The term “acute” (in acute/active ABMR) is confusing to clinicians, and consequently it has been removed from the Banff classification” | mechanisms[1] |
| mechanism | AND THE SURVEY SAYS HOW THE VOCABULARY IS MISREAD, NOT ONLY THAT IT IS: `Clinicians often fail to recognize chronic elements of ABMR (eg, cg >0)` and are `more likely to consider a diagnosis of chronic, active ABMR if C4d is negative, even if there is no TG, PTCBML, or IFTA`. A named direction of error against a named criterion— “Survey regarding clinical practice related to highly sensitized patients indicates that: Clinicians often fail to recognize chronic elements of ABMR (eg, cg >0) Clinicians more likely to consider a diagnosis of chronic, active ABMR if C4d is negative, even if there is no TG, PTCBML, or IFTA” | mechanisms[2] |
| mechanism | AND A FEATURE EXCLUDED IN 1991 WAS ADMITTED IN 2017 BECAUSE THE POPULATION CHANGED, NOT THE FEATURE: `The nonspecificity of i-IFTA for rejection, proved by the fact that it occurs in native kidneys, was the main reason why i-IFTA and tubulitis in atrophic tubules was specifically excluded from the classification at the first Banff meeting. However, since 1991, immunosuppression has changed and graft survival improved with more patients presenting late posttransplantation with i-IFTA.` The lesion is exactly as nonspecific as it was; what moved is who gets biopsied— “The nonspecificity of i‐IFTA for rejection, proved by the fact that it occurs in native kidneys, was the main reason why i‐IFTA and tubulitis in atrophic tubules was specifically excluded from the classification at the first Banff meeting. However, since 1991, immunosuppression has changed and graft survival improved with more patients… | mechanisms[3] |
| mechanism | AND A CATEGORY WAS DELIBERATELY NOT CREATED, BECAUSE ITS ANALOGUE PROVED UNDEFINABLE: `there is no borderline or suspicious category for chronic active TCMR, particularly as this category within acute TCMR has proved to be troublesome for treating clinicians and even for pathologists to define`. An absence with a stated reason - a committee declining to mint a term because the existing one of that shape does not work— “At this point, there is no borderline or suspicious category for chronic active TCMR, particularly as this category within acute TCMR has proved to be troublesome for treating clinicians and even for pathologists to define (see Tables 3 and 4 of ref. 1). Furthermore, low levels of i‐IFTA (i‐IFTA 1) and mild tubulitis within foci of IFTA were… | mechanisms[4] |
| mechanism | AND A LABELLING RULE EXISTS TO STOP THE SAME BIOPSY BEING COUNTED TWICE: `a biopsy fulfilling the diagnostic criteria for chronic active TCMR should not be given A SECOND DIAGNOSIS of Borderline or acute TCMR, because the latter already addresses the acute/ACTIVE COMPONENT` - while `biopsies with chronic active TCMR can have an additional diagnosis of ABMR`. Which co-diagnoses are permitted is part of the definition, and it is stated separately from the criteria— “Inflammation in non‐IFTA and IFTA areas can coexist in the same biopsy specimen. Such biopsy specimens should still be diagnosed as chronic active TCMR and not labeled acute plus chronic active TCMR, because the latter already addresses the acute/active component in the rejection process. In other words, a biopsy fulfilling the diagnostic… | mechanisms[5] |
| mechanism | AND THE MARKER PROPOSED AS A TRIAL ENDPOINT HAS THE SAME PROBLEM ONE LAYER DOWN: `current shortcomings of DSA testing (variability in test methods, diagnostic threshold definitions, clinical significance standards) are known to limit its utility as a sole endpoint`, with `titration rather than mean fluorescence intensity to reveal oversaturation`. The definitional instability the meeting exists to fix in histology is present, unfixed, in the biomarker offered to replace it— “To be a potential surrogate endpoint, anti‐HLA DSAs have not only to be considered within the context of their potential limitations (titration rather than mean fluorescence intensity to reveal oversaturation) but also by integrating their properties (eg, complement activating capacity, IgG subclasses, cytotoxic effect). However, current… | mechanisms[6] |
| extends | the Banff 2015 meeting report, which named chronic active TCMR in the vascular compartment but gave no criteria for the tubulointerstitial one— “In confirmation of previous studies, it was independently demonstrated by 2 groups that i‐ IFTA is associated with reduced graft survival. Furthermore, these groups presented that i‐ IFTA , particularly when involving >25% of sclerotic cortex in association with tubulitis, is often a sequela of acute TCMR in association with… | claim_relations[0] |
| extends | the first Banff meeting of 1991, which specifically EXCLUDED i-IFTA and tubulitis in atrophic tubules from the classification - this report reverses that exclusion and gives the reason— “The nonspecificity of i‐IFTA for rejection, proved by the fact that it occurs in native kidneys, was the main reason why i‐IFTA and tubulitis in atrophic tubules was specifically excluded from the classification at the first Banff meeting. However, since 1991, immunosuppression has changed and graft survival improved with more patients… | claim_relations[1] |
| sense | `chronic active TCMR` (Banff 2017) - EXTENDED to the tubulointerstitial compartment: i-IFTA score 2-3 WITH tubulitis t2-3 in all but severely atrophic tubules, inflammation in >25% of total cortex, and other causes of i-IFTA ruled out. Banff 2015 named the entity in the vascular compartment only— “Thus, at present and to minimize overdiagnosis, tubulointerstitial lesions of chronic active TCMR have been added to the working classification (Table 5 ) as a combination of i‐IFTA and tubulitis involving all but severely atrophic tubules, with moderately high thresholds for both (i‐IFTA2‐3; t2‐3), a requirement for inflammation involving… | senses[0] |
| sense | `acute/active ABMR` (before 2017) vs `active ABMR` (2017 on) - THE SAME CATEGORY WITH A WORD DELETED, `because the term `acute` ... is confusing to clinicians`— “The term “acute” (in acute/active ABMR) is confusing to clinicians, and consequently it has been removed from the Banff classification” | senses[1] |
| sense | `i-IFTA` - `inflammation in areas of interstitial fibrosis and tubular atrophy`: `EXCLUDED from the classification` in 1991 for nonspecificity, admitted in 2017 in conjunction with tubulitis— “The nonspecificity of i‐IFTA for rejection, proved by the fact that it occurs in native kidneys, was the main reason why i‐IFTA and tubulitis in atrophic tubules was specifically excluded from the classification at the first Banff meeting. However, since 1991, immunosuppression has changed and graft survival improved with more patients… | senses[2] |
| sense | `borderline` - a category that exists WITHIN acute TCMR and was deliberately NOT created for chronic active TCMR, because the existing one `has proved to be troublesome for treating clinicians and even for pathologists to define`— “At this point, there is no borderline or suspicious category for chronic active TCMR, particularly as this category within acute TCMR has proved to be troublesome for treating clinicians and even for pathologists to define (see Tables 3 and 4 of ref. 1). Furthermore, low levels of i‐IFTA (i‐IFTA 1) and mild tubulitis within foci of IFTA were… | senses[3] |
| control | the occurrence of i-IFTA in NATIVE (non-transplanted) kidneys - a population in which rejection is impossible — held— “Clearly, i‐IFTA is not a specific lesion, and adding i‐IFTA by itself, even if moderate to severe, to the classification as diagnostic of chronic active TCMR does not appear warranted based on present data. It is well known that many other disease processes, including BK virus infection, pyelonephritis, ABMR, recurrent glomerulonephritis, and… — rules out the reading of i-IFTA as a rejection-specific lesion; it is the negative control that kept the lesion out of the classification for 26 years— “The nonspecificity of i‐IFTA for rejection, proved by the fact that it occurs in native kidneys, was the main reason why i‐IFTA and tubulitis in atrophic tubules was specifically excluded from the classification at the first Banff meeting. However, since 1991, immunosuppression has changed and graft survival improved with more patients… | controls[0] |
| control | requiring tubulitis (t2-3) ALONGSIDE i-IFTA (2-3), inflammation in >25% of total cortex, and explicit exclusion of chronic pyelonephritis and BK nephropathy — held — rules out overdiagnosis of chronic active TCMR from a lesion the paper calls nonspecific in the same section Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | controls[1] |
| control | grading of i-IFTA by 3 pathologists against the Banff 2015 criteria — partial Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. — rules out the objection that i-IFTA cannot be scored reproducibly, 'as scattered inflammatory cells are often seen in what might be considered by many pathologists to be bland fibrosis' Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | controls[2] |
| weight | the Banff 2015 meeting report, which named chronic active TCMR in the vascular compartment but gave no criteria for the tubulointerstitial one — 0.9 Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | claim_relations[0] |
| weight | the first Banff meeting of 1991, which specifically EXCLUDED i-IFTA and tubulitis in atrophic tubules from the classification - this report reverses that exclusion and gives the reason — 0.85 Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | claim_relations[1] |
| note | chronic active TCMR —distinct-from→ acute TCMR — 'a biopsy fulfilling…' - the two categories are kept apart by a rule about co-diagnosis, not by a difference in lesion Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[0] |
| relation | chronic active TCMR —distinct-from→ acute TCMR — the two categories are kept apart by a rule about CO-DIAGNOSIS: a biopsy meeting the chronic active criteria may NOT also be called Borderline or acute TCMR Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[0] |
| weight | chronic active TCMR —distinct-from→ acute TCMR — 0.95 Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[0] |
| note | titration —contrasted-with→ mean fluorescence intensity — 'TITRATION RATHER…' - two readouts of the same antibody, one preferred because the other has a ceiling. The instrument's dynamic range decides which number the endpoint is made of Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[1] |
| relation | titration —contrasted-with→ mean fluorescence intensity — two readouts of the same antibody, one preferred RATHER THAN the other because the other saturates Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[1] |
| weight | titration —contrasted-with→ mean fluorescence intensity — 0.95 Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[1] |
| audit | borderline —part-of→ acute TCMR — Audit 2026-09-28: DOUBTFUL - read against its span and kept, but the borderline category exists within acute TCMR; part-of is loose. Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[2] |
| note | borderline —part-of→ acute TCMR — 'there is NO BORDERLINE…' - the borderline category belongs to acute TCMR and was deliberately withheld from the new one. Weight 0.85: the clause asserts the containment in a subordinate aside, in the course of denying its twin Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[2] |
| relation | borderline —part-of→ acute TCMR — the borderline category exists WITHIN acute TCMR - asserted in the aside that denies the same category to chronic active TCMR Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[2] |
| weight | borderline —part-of→ acute TCMR — 0.85 Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concept_edges[2] |
| outcome | control — held Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | controls[0] |
| outcome | control — held Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | controls[1] |
| outcome | control — partial Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | controls[2] |
| limitation | THE LESION ADMITTED TO THE CLASSIFICATION IS NOT SPECIFIC AND THE PAPER SAYS SO BEFORE ADMITTING IT: `Clearly, i-IFTA is not a specific lesion, and adding i-IFTA by itself, even if moderate to severe, to the classification as diagnostic of chronic active TCMR does not appear warranted based on present data. It is well known that many other disease processes, including BK virus infection, pyelonephritis, ABMR, recurrent glomerulonephritis, and obstruction, may at some point present with i-IFTA.` The criterion is therefore a CONJUNCTION with tubulitis plus an exclusion list, not the lesion alone Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | limitations[0] |
| limitation | AND THE THRESHOLDS ARE SET WHERE THE OUTCOME ASSOCIATION STARTS, IN ONE COHORT: `i-IFTA scores of 2 and 3, but not 1, as well as t2 and t3 tubulitis (but not t1) within areas of IFTA, excluding severely atrophic tubules, were associated with an increased rate of graft loss.` The class boundary is drawn at the point where a prognostic signal appears - the same move as the ARF/AKI classifications in this corpus, and it inherits that cohort's population Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | limitations[1] |
| limitation | and the committee names its own strategy rather than presenting the choice as forced: `This conservative approach has served the Banff group well in the past, with the introduction of C4d-negative ABMR. As with the latter, future modifications will be considered as new data emerge`. The classification is explicitly provisional, with the revision mechanism part of the publication Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | limitations[2] |
| limitation | and the agreement figure behind the new criterion is three pathologists in one centre: `the Paris group reported GOOD AGREEMENT AMONG 3 PATHOLOGISTS in grading i-IFTA according to the Banff 2015 criteria, with complete agreement between all 3 PATHOLOGISTS IN 101 (67%) OF 150 CASES, and a KAPPA VALUE OF .62` - which is reported as good, and sits below this project's own controlled-vocabulary kappa of 0.702 Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | limitations[3] |
finding · quantity · variable · definition · key-term — grounded in the full text| finding | Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.findings[0] |
| finding | Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.findings[1] |
| finding | Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.findings[2] |
| finding | Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.findings[3] |
| finding | Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.findings[4] |
| finding | Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.findings[5] |
| quantity | kappa 0.62 — Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.quantities[0] |
| quantity | >25% of total cortex — Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.quantities[1] |
| quantity | i-IFTA 2-3 and t2-3 — Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.quantities[2] |
| variable | i-IFTA score Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.variables[0] |
| definition | chronic active TCMR Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.definitions[0] |
| definition | severely atrophic tubules Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.definitions[1] |
| concept | chronic active TCMR — not defined in this paper's own words; the category whose criteria this meeting extended into the tubulointerstitial compartment Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concepts[0] |
| concept | acute TCMR — not defined in this paper's own words; the pre-existing category, kept separate by an explicit rule against a second diagnosis Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concepts[1] |
| concept | borderline — not defined in this paper's own words; the equivocal category that exists inside acute TCMR and was withheld from chronic active TCMR on the grounds that it is troublesome to define Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concepts[2] |
| concept | i‐IFTA — not defined in this paper's own words; inflammation in areas of interstitial fibrosis and tubular atrophy - the lesion excluded in 1991 and admitted in 2017 Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concepts[3] |
| concept | tubulitis — not defined in this paper's own words; the co-required lesion: i-IFTA alone was judged too nonspecific to be diagnostic Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concepts[4] |
| concept | titration — not defined in this paper's own words; the DSA readout preferred at this meeting because the alternative saturates Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concepts[5] |
| concept | mean fluorescence intensity — not defined in this paper's own words; the conventional DSA readout, named here as the one that can oversaturate Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | concepts[6] |
| kappa | Quotation withheld — this paper is not ours to reproduce, and the page has already quoted as much of it as the rights layer allows. The tag, its field and its confidence stand; the sentence is at the publisher. | content_tags.statistics[0] |
When we have changed our mind. Some entries in the table begin with a word in capitals and the reason for it. EVIDENCE CORRECTED — the finding still stands, but we had quoted the wrong sentence from the paper, and the quotation has been replaced with the right one. RETRACTED — the entry itself was wrong; it stays on the page, marked, with the reason, rather than being deleted. WITHDRAWN AND REPLACED — the entry was wrong, and a corrected version of it appears in the entries below. Each mark carries its own reason, in brackets, because the reasons differ from one entry to the next. An entry we have WITHDRAWN is removed from this page and kept in the record, with its reason. A line reading Audit and a date is a later re-reading of the entry against its whole sentence: DOUBTFUL means it was kept, and the reason says what is loose about it. Quotation marks inside the tagger's sentence. Where a tag is the tagger's own sentence, a phrase in quotation marks inside it is borrowed from the paper — the tagger's wording around it is not. The paper's own sentence is the evidence quote for that row; on this page it is withheld with the article, and the article is at its publisher. Nothing inside quotation marks anywhere on this page is ours: if it is quoted, it is the paper's. Whose words a concept carries. A concept entry records a term the paper itself uses, so the term, the sense given for it, and its evidence are the paper's own words, quoted where the paper fixes them. This is the opposite of a sense entry in the tag table, which is the tagger's sentence about how the paper uses a term. Where a concept entry could not be grounded in the paper's words, the entry says so on its own row.
Tag layer © the Meta-Tagging Project, CC BY 4.0. The paper text is © its authors/publisher
and is linked, not reproduced. Excerpts shown are short quotations for identification and verification.
· back to index
· concepts · authors
· עברית
© 2026 Shir Sivroni · ORCID 0009-0000-2597-2824